FindTrial
Sign In

Study of next-generation sequencing technique based on whole genome in the diagnosis of sepsis pathogen

Study of next-generation sequencing technique based on whole genome in the diagnosis of sepsis pathogen

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015176
Enrollment
Unknown
Registered
2018-03-12
Start date
2018-03-19
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Gold Standard:According to the microbial culture method to determine whether the presence of microbes in clinical samples.
Index test:Whether&#32
the&#32
microbial&#32
culture&#32
is&#32
positive,&#32
if&#32
it&#32
type&#32
of&#32
identification&#32
and&#32
relative&#32
quantity.

Sponsors

Shenzhen People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients that were accepted in the intensive care unit and be diagnosed as sepsis; 2. aged=18 years old; 3. PCT = 0.5 ng/ml.

Exclusion criteria

Exclusion criteria: 1. Patients with solid or hematologic malignancies; 2. Patients dead or discharge within 24 hours in hospital; 3. Patients that couldn't be cured in accordance with the 2012 international sepsis diagnosis and treatment guidelines for various reasons.

Design outcomes

Primary

MeasureTime frame
Pathogen detection rate;—

Secondary

MeasureTime frame
mortality rate;—

Countries

China

Contacts

Public ContactLiu Xueyan

Shenzhen People's Hospital

liuliu_512@qq.com+86 13554843721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026